Turkish Compliance and Adaptation of EULAR 2013 Recommendations for the Management of Rheumatoid Arthritis with Synthetic and Biological Disease-Modifying Antirheumatic Drugs: Expert Opinion of TLAR

Basit Öğe Kaydı
dc.authoridHilal Kocabaş: 0000-0002-3309-2998
dc.contributor.authorAtaman, Şebnem
dc.contributor.authorSarı Sürmeli, Zühre
dc.contributor.authorSunar, İsmihan
dc.contributor.authorÖzdemirel, Erhan
dc.contributor.authorAkıncı, Ayşen
dc.contributor.authorBodur, Hatice
dc.contributor.authorKocabaş, Hilalen_US
dc.contributor.authorAkgül, Özgür
dc.contributor.authorAltan, Lale
dc.contributor.authorAltay, Zuhal
dc.contributor.authorAyhan, Figen
dc.contributor.authorBirtane, Murat
dc.contributor.authorSoy Buğdaycı, Derya
dc.contributor.authorÇapkıni Erhan
dc.contributor.authorCerrahoğlu, Lale
dc.contributor.authorDuruöz, Mehmet Tuncay
dc.contributor.authorGünaydın, Rezzan
dc.contributor.authorGünendi, Zafer
dc.contributor.authorGürer, Gülcan
dc.contributor.authorBal, Ajda
dc.contributor.authorKaçar, Cahit
dc.contributor.authorKaptanoğlu, Ece
dc.contributor.authorKaya, Taciser
dc.contributor.authorKotevoğlu, Nurdan
dc.contributor.authorNas, Kemal
dc.contributor.authorRezvani, Aylin
dc.contributor.authorŞen, Nesrin
dc.contributor.authorŞendur, Ömer Faruk
dc.contributor.authorYalçın, Peyman
dc.date.accessioned2020-01-18T21:02:59Z
dc.date.available2020-01-18T21:02:59Z
dc.date.issued2015
dc.departmentNEÜ, Meram Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalıen_US
dc.descriptionWOS:000366027100001en_US
dc.description.abstractObjectives: This study aims to report Turkish League Against Rheumatisms assessment on the compliance of European League Against Rheumatism 2013 treatment recommendations for rheumatoid arthritis with practices in Turkish rheumatology clinics and adaptations for Turkey. Patients and methods: Members of Turkish League Against Rheumatism and one rheumatoid arthritis patient voted for the 2013 recommendations of the European League Against Rheumatism for treatment of rheumatoid arthritis in two sessions. An item was changed and voted again only if at least 70% of participants wanted a change. Strength of recommendations was calculated for the items. Strength of recommendations for the changed items in the first and second voting rounds was compared by Wilcoxon signed-rank test. In case of significant difference, the item with higher strength of recommendation was accepted. In case of no difference, the changed item was selected. Results: Three overarching principles and fourteen recommendations were assessed among which the three overarching principles were changed emphasizing the importance of physiatrists as well as rheumatologists for taking care of the patients. Third item was changed by adding composite indices for assessing disease activity. In the ninth recommendation, rituximab was suggested as a first line drug independent of situations like latent tuberculosis or lymphoma, etc. In the 11th recommendation, unlike European League Against Rheumatism, our committee did not suggest any thought about tofacitinib, as then it had not been approved in Turkey. Remaining principles were accepted as the same. Conclusion: Expert opinion of Turkish League Against Rheumatism for treatment of rheumatoid arthritis patients was formed for practices in Turkish clinics. Conflict of Interest The authors declared no conflicts of interest with respect to the authorship and/or publication of this article. Financial Disclosure The authors received no financial support for the research and/or authorship of this article.en_US
dc.identifier.citationKocabaş, H., Ataman, Ş., Sarı Sürmeli., Z., Sunar, İ., Özdemirel, E., Akıncı, A., Bodur, H., Akgül, Ö., Altan, L., Altay, Z., Ayhan, F., Birtane, M., Soy Buğdaycı, D., Çapkın, E., Cerrahoğlu, L., Duruöz, M. T., Günaydın, R., Günendi, Z., Gürer, G., Bal, A., Kaçar, C., Kaptanoğlu, E., Kaya, T., Kotevoğlu, N., Nas, K., Rezvani, A., Şen, N., Şendur, Ö. F., Yalçın, P. (2015). Turkish compliance and adaptation of EULAR 2013 recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: Expert opinion of TLAR. Archives of Rheumatology, 30, 4, 271-284.en_US
dc.identifier.doi10.5606/ArchRheumatol.2015.5654en_US
dc.identifier.endpage284en_US
dc.identifier.issn2148-5046en_US
dc.identifier.issn2618-6500en_US
dc.identifier.issue4en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage271en_US
dc.identifier.urihttps://app.trdizin.gov.tr/makale/TVRnNU16UTVPUT09/turkish-compliance-and-adaptation-of-eular-2013-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic-and-biological-disease-modifying-antirheumatic-drugs-expert-opinion-of-tlar
dc.identifier.urihttps://hdl.handle.net/20.500.12452/1398
dc.identifier.volume30en_US
dc.identifier.wosWOS:000366027100001en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofArchives of Rheumatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US]
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBiologic disease modifying anti-rheumatic drugsen_US
dc.subjectRheumatoid arthritisen_US
dc.subjectSynthetic disease modifying anti-rheumatic drugsen_US
dc.subjectTreatment eecommendations
dc.titleTurkish Compliance and Adaptation of EULAR 2013 Recommendations for the Management of Rheumatoid Arthritis with Synthetic and Biological Disease-Modifying Antirheumatic Drugs: Expert Opinion of TLARen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Ataman, Şebnem.pdf
Boyut:
412.31 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin/ Full Text
İndir

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu